首页 > 最新文献

Journal of Retina-Vitreous最新文献

英文 中文
Central serous chorioretinopathy developed following covid-19 vaccine covid-19疫苗接种后出现中枢性浆液性脉络膜视网膜病变
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.12
M. Coşkun
A 40-year-old male patient, an office worker, is a hospital staff. He applied with the complaint of sudden onset of blurred vision in the right eye. He stated that he had the first dose of inactivated covid vaccine (sinovac) 4 days ago in his story. In his examination, his vision was 0.5 in the right eye, 1.0 in the left eye, and his intraocular pressure was in both eyes. It was at the level of 15 mmHg. Biomicroscopically, the anterior segment looked natural. CSC was diagnosed in the FFA and OCT examinations.Treatment with oral acetazolamide (2x250 mg), topical nepafanac (4x1) was started. On the 13th day of the treatment, there was insufficient improvement in clinical findings, and oral acetazolamide was used. The dose was reduced (2x125 mg), oral epleronone (50 mg) was added. On the 70th day of the treatment, the vision in the right eye increased to full level in the control examination and it was observed that the retina returned to its normal appearance in the OCT examination.Copyright © 2023 Gazi Eye Foundation. All rights reserved.
患者男,40岁,办公室职员,是医院职员。他以右眼突然视力模糊为主诉来申请的。他在4天前的故事中说,他接种了第一剂灭活疫苗(sinovac)。检查右眼视力0.5,左眼视力1.0,双眼眼压均为正常。在15毫米汞柱的水平。生物显微镜下,前段看起来很自然。经FFA和OCT检查诊断为CSC。开始口服acetazolamide (2x250 mg),外用neafanac (4x1)。治疗第13天,临床表现改善不足,改用口服乙酰唑胺。减少剂量(2 × 125 mg),加入口服依普利酮(50 mg)。治疗第70天,对照检查右眼视力恢复正常,OCT检查视网膜恢复正常。版权所有©2023加兹眼科基金会。版权所有。
{"title":"Central serous chorioretinopathy developed following covid-19 vaccine","authors":"M. Coşkun","doi":"10.37845/ret.vit.2023.32.12","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.12","url":null,"abstract":"A 40-year-old male patient, an office worker, is a hospital staff. He applied with the complaint of sudden onset of blurred vision in the right eye. He stated that he had the first dose of inactivated covid vaccine (sinovac) 4 days ago in his story. In his examination, his vision was 0.5 in the right eye, 1.0 in the left eye, and his intraocular pressure was in both eyes. It was at the level of 15 mmHg. Biomicroscopically, the anterior segment looked natural. CSC was diagnosed in the FFA and OCT examinations.Treatment with oral acetazolamide (2x250 mg), topical nepafanac (4x1) was started. On the 13th day of the treatment, there was insufficient improvement in clinical findings, and oral acetazolamide was used. The dose was reduced (2x125 mg), oral epleronone (50 mg) was added. On the 70th day of the treatment, the vision in the right eye increased to full level in the control examination and it was observed that the retina returned to its normal appearance in the OCT examination.Copyright © 2023 Gazi Eye Foundation. All rights reserved.","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73653312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A case of acute central serous chorioretinopathy after immunization with covid-19 mrna vaccine covid-19 mrna疫苗免疫后急性中枢性浆液性脉络膜视网膜病变1例
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.24
Anıl Güngör, Berrak Şekeryapan Gediz
{"title":"A case of acute central serous chorioretinopathy after immunization with covid-19 mrna vaccine","authors":"Anıl Güngör, Berrak Şekeryapan Gediz","doi":"10.37845/ret.vit.2023.32.24","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.24","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72575998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of covid-19 who developed cilioretinal artery obstruction associated with impending central retinal vein occlusion after covid-19 infection covid-19感染后发生睫状视网膜动脉阻塞并视网膜中央静脉阻塞1例
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.33
Eyüpcan Şensoy, Berrak Sekeryapan Gediz
{"title":"A case of covid-19 who developed cilioretinal artery obstruction associated with impending central retinal vein occlusion after covid-19 infection","authors":"Eyüpcan Şensoy, Berrak Sekeryapan Gediz","doi":"10.37845/ret.vit.2023.32.33","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.33","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91181936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pars plana vitrectomy for central retinal artery occlusion without emboli 玻璃体切除术治疗视网膜中央动脉闭塞无栓塞
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.22
Ö. Kayıkçıoğlu, S. Doğruya, Beyza Tekin Altınbay, M. Altınışık, E. Kurt
Purpose: The results of patients who had 23-G pars plana vitrectomy (PPV) unresponsive to medical therapy for central retinal artery occlusion without visible embolization are presented. Materials and Methods: We operated on eight patients who were treated for acute central retinal artery occlusion without visible emboli in our clinic. We started emergency medical treatment following diagnosis which was unsuccessfull. Afterwards, the patient had PPV in six cases and PPV- trabeculectomy in two cases. During the operation we applied intraoperative hypotonia for ten minutes and we tried to restore retinal circulation with fluid turbulance on optic nerve head. While visual acuity remained at the basal level in five patients (hand movement positive), slight increase was observed in three patients (preop P (-), 20 cmFC, 2 mFC, ; postop 30 cmFC, 30 cmFC, 0.1 respectively). Discussion and Conclusion: Primary pars plana vitrectomy and surgical hypotonia may be an early treatment option for central retinal artery occlusion without visible emboli, which should be evaluated in large scale studies.
目的:介绍23-G玻璃体切割(PPV)治疗视网膜中央动脉闭塞无明显栓塞的临床疗效。材料与方法:对8例急性视网膜中央动脉闭塞无明显栓塞的患者进行手术治疗。我们在诊断后进行了紧急治疗,但没有成功。之后,6例患者行PPV, 2例行PPV-小梁切除术。术中应用术中低张力10分钟,视神经头处液体湍流,试图恢复视网膜循环。5例患者的视力保持在基础水平(手部运动阳性),3例患者的视力略有增加(术前P (-), 20 cmFC, 2 mFC,;poststop 30 cmFC, 30 cmFC, 0.1)。讨论与结论:原发性玻璃体切割和手术低张力可能是视网膜中央动脉闭塞无明显栓塞的早期治疗选择,应在大规模研究中进行评估。
{"title":"Pars plana vitrectomy for central retinal artery occlusion without emboli","authors":"Ö. Kayıkçıoğlu, S. Doğruya, Beyza Tekin Altınbay, M. Altınışık, E. Kurt","doi":"10.37845/ret.vit.2023.32.22","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.22","url":null,"abstract":"Purpose: The results of patients who had 23-G pars plana vitrectomy (PPV) unresponsive to medical therapy for central retinal artery occlusion without visible embolization are presented. Materials and Methods: We operated on eight patients who were treated for acute central retinal artery occlusion without visible emboli in our clinic. We started emergency medical treatment following diagnosis which was unsuccessfull. Afterwards, the patient had PPV in six cases and PPV- trabeculectomy in two cases. During the operation we applied intraoperative hypotonia for ten minutes and we tried to restore retinal circulation with fluid turbulance on optic nerve head. While visual acuity remained at the basal level in five patients (hand movement positive), slight increase was observed in three patients (preop P (-), 20 cmFC, 2 mFC, ; postop 30 cmFC, 30 cmFC, 0.1 respectively). Discussion and Conclusion: Primary pars plana vitrectomy and surgical hypotonia may be an early treatment option for central retinal artery occlusion without visible emboli, which should be evaluated in large scale studies.","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82369621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of clinical features and visual outcome in traumatic and non-traumatic aetiologies in tertiary eye care center of western india 印度西部三级眼科保健中心创伤性与非创伤性病因的临床特征及视力结果比较研究
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.2
M. Shah, Shreya Shah, Rupali Barnwal, Pradeep Chandana, D. Thorat
{"title":"Comparative study of clinical features and visual outcome in traumatic and non-traumatic aetiologies in tertiary eye care center of western india","authors":"M. Shah, Shreya Shah, Rupali Barnwal, Pradeep Chandana, D. Thorat","doi":"10.37845/ret.vit.2023.32.2","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.2","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77643436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report of solar retinopathy related to partial solar eclipse 日偏食致太阳视网膜病变1例
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.37
Irfan Akaray, R. Garip
{"title":"Case report of solar retinopathy related to partial solar eclipse","authors":"Irfan Akaray, R. Garip","doi":"10.37845/ret.vit.2023.32.37","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.37","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83786591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The incidence of central serous chorioretinopathy in bank employees 银行职员中枢性浆液性脉络膜视网膜病变的发病率
Pub Date : 2023-01-01 DOI: 10.37845/ret.vit.2023.32.21
M. Aksoy, Ali Küçüködük, Seyrek Lütfi
{"title":"The incidence of central serous chorioretinopathy in bank employees","authors":"M. Aksoy, Ali Küçüködük, Seyrek Lütfi","doi":"10.37845/ret.vit.2023.32.21","DOIUrl":"https://doi.org/10.37845/ret.vit.2023.32.21","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"90 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84088639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Compliance with the Recommended Age-related Eye Disease Study 2 Supplementation among Korean Age-related Macular Degeneration Patients 韩国年龄相关性黄斑变性患者对推荐的年龄相关性眼病研究2补充的依从性
Pub Date : 2022-11-30 DOI: 10.21561/jor.2022.7.2.121
Yoon Jeong, S. Woo
{"title":"Compliance with the Recommended Age-related Eye Disease Study 2 Supplementation among Korean Age-related Macular Degeneration Patients","authors":"Yoon Jeong, S. Woo","doi":"10.21561/jor.2022.7.2.121","DOIUrl":"https://doi.org/10.21561/jor.2022.7.2.121","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"106 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88086708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Two Three-dimensional Visualization Systems: A Consecutive Series and Descriptive Analysis of 296 Cases 两种三维可视化系统的比较:296例连续系列和描述性分析
Pub Date : 2022-11-30 DOI: 10.21561/jor.2022.7.2.89
Y. Mun, K. Park
{"title":"Comparison of Two Three-dimensional Visualization Systems: A Consecutive Series and Descriptive Analysis of 296 Cases","authors":"Y. Mun, K. Park","doi":"10.21561/jor.2022.7.2.89","DOIUrl":"https://doi.org/10.21561/jor.2022.7.2.89","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"196 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75893147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Real-world Treatment Outcomes between Type 1 and Type 2 Choroidal Neovascularization 1型和2型脉络膜新生血管的实际治疗效果比较
Pub Date : 2022-11-30 DOI: 10.21561/jor.2022.7.2.98
Mi Jeong Kim, Ki Seok Kim, H. Yang
{"title":"Comparison of Real-world Treatment Outcomes between Type 1 and Type 2 Choroidal Neovascularization","authors":"Mi Jeong Kim, Ki Seok Kim, H. Yang","doi":"10.21561/jor.2022.7.2.98","DOIUrl":"https://doi.org/10.21561/jor.2022.7.2.98","url":null,"abstract":"","PeriodicalId":17086,"journal":{"name":"Journal of Retina-Vitreous","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84277705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Retina-Vitreous
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1